CD38 and lymphoma: Lymphoma typically occurs in multiple lesions and is sensitive to radiation therapy.[12] CD38 has been found to be highly expressed for some lymphoma such as MM.[25] The first anti‐CD38‐humanized mAb daratumumab was subsequently approved for the treatment of relapsed MM.